Avellino Labs provides eye care professionals with a rapid and inexpensive screening test to further ensure patients cleared for refractive surgery are good candidates. It tests for multiple single point gene mutations associated with the most common types of corneal dystrophy, a condition that may not affect vision until triggered by refractive surgery.

Visite el sitio web de Avellino

Suscribirse a las actualizaciones

Una actualización semanal de lo que hay en la Agenda Global

© 2021 World Economic Forum

Política de privacidad y normas de uso